Samenvatting
The aim of this paper is to study the use of BROMAZEPAM on the alertness and psychomotor performance versus placebo in a homogeneous population of healthy volunteers. Results show that on the whole, as far as the effect of treatment is concerned, no impairment of performance nor alertness is observed in the subjects receiving 6 or 12 mg BROMAZEPAM.